AzTrials
AzTrials

Intermittent ClaudicationPhase 3EXERTNCT00895635

Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)

A Phase 3 study testing Treadmill Exercise Training and Arm Ergometry Exercise Training in people with Intermittent Claudication and Peripheral Vascular Diseases, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Peripheral arterial disease (PAD) is a disorder that affects more than 8 million people in the United States. As a result of decreased blood flow to the legs, people with PAD may experience leg pain and difficulty with walking. Read more about this study

Who is it for?
Ages 18 to 90 years
What is being tested?
Treadmill Exercise Training and Arm Ergometry Exercise Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
1 siteUnited States
Study dates
Jan 2009to Apr 2014
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Has lifestyle-limiting claudication
  • Able to walk on a treadmill at 2 mph
  • Able to perform arm ergometry exercise
  • Able to complete a 12-week exercise program

Who cannot join

  • Physical activities are limited for reasons other than claudication
  • Uncontrolled high blood pressure
  • Uncontrolled diabetes
  • Unstable coronary heart disease
  • Ischemic rest pain or tissue loss
  • Recent (in the 3 months before study entry) coronary or peripheral revascularization

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Minnesota

    Minneapolis, Minnesota, 55455

Other trials in United States

About this study

Official title: Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking

Peripheral arterial disease (PAD) is a disorder that affects more than 8 million people in the United States. As a result of decreased blood flow to the legs, people with PAD may experience leg pain and difficulty with walking. This study will examine the effectiveness of two exercise programs-a treadmill walking program and an aerobic arm exercise program-at increasing walking distance and decreasing leg pain in people with PAD.

Read the detailed description

PAD is a condition that occurs when atherosclerotic plaque builds up in the peripheral arteries and restricts blood flow. People with PAD often experience reduced blood flow to the legs, which may cause painful leg cramping while walking, known as intermittent claudication. Claudication affects over 4 million people in the United States, and many people with this condition can walk only ½ to 2 blocks before leg pain begins to occur. Regular treadmill walking has been shown to be effective at increasing walking distance and reducing claudication in people with PAD. However, walking on a treadmill may prove difficult for some people with PAD and usually causes increased leg pain, both of which may reduce exercise frequency. Aerobic arm exercises do not cause leg pain and may be an effective way for people with PAD to improve overall cardiovascular fitness and increase the amount of exercise they do. The purpose of this study is to compare the effectiveness of a treadmill exercise program and an aerobic arm exercise program at reducing symptoms of claudication and improving walking ability in people with PAD.

This study will enroll people with PAD and claudication. At a baseline study visit, participants will complete a treadmill walking test; a blood collection; and questionnaires to assess walking status, daily activity levels, quality of life, and mood. One week after the baseline visit, participants will attend a study visit for an assessment of forearm and leg muscle blood flow and a hand-bike test that will measure upper body strength using an arm cycle ergometer. The ergometer is a device with bicycle pedals that people move using their arms. Participants will then be randomly assigned to either a treadmill exercise training program, an arm ergometry exercise program, or a control group.

Participants in the treadmill exercise training program will attend a supervised program at one of four study sites and exercise on a treadmill for 1 hour three times a week for 12 weeks. Participants in the arm ergometry exercise program will attend a supervised program at one of four study sites and exercise using an arm cycle ergometer (hand-bike) for 1 hour three times a week for 12 weeks. Participants in both groups will also receive written instructions about exercising on their own. Participants in the control group will continue to receive usual care from their regular doctor for the treatment of PAD and will be provided with written exercise instructions. Once a week for 12 weeks, participants in the control group will attend study visits to discuss any health problems.

All participants will be asked to monitor their daily exercise for 3 separate weeks during the 12-week period by wearing an accelerometer, which will measure and record physical activity. They will also record their exercise habits in a written diary. All participants will attend study visits on 2 separate days at Weeks 6 and 12 for repeat baseline testing.

From Weeks 12 to 24, all participants will be encouraged to continue to exercise on their own at least three times a week for 30 minutes. Every 4 weeks, study researchers will call participants to offer encouragement and answer questions. At Week 23, participants will again wear an accelerometer and keep an exercise diary for 1 week. All participants will attend a final study visit at Week 24 for repeat baseline testing.

Being tested
Treadmill Exercise Training, Arm Ergometry Exercise Training, Usual Care
Keywords
Claudication, Peripheral Arterial Disease, Exercise Rehabilitation, Cardiovascular Function
Medical subject headings
Intermittent Claudication, Peripheral Vascular Diseases, Peripheral Arterial Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treadmill Exercise TrainingBehavioural

    60-minute sessions of supervised treadmill exercise training three times a week for 12 weeks

  • Arm Ergometry Exercise TrainingBehavioural

    60-minute sessions of supervised aerobic arm exercise training using an arm ergometer three times a week for 12 weeks

  • Usual CareBehavioural

    Usual care for PAD

Study groups in NCT00895635
Study groupRoleWhat they receive
Treadmill Exercise TrainingExperimentalParticipants will take part in a 12-week supervised treadmill exercise training program.
Receives: Behavioral: Treadmill Exercise Training
Arm Ergometry Exercise TrainingExperimentalParticipants will take part in a 12-week supervised aerobic arm ergometry exercise training program.
Receives: Behavioral: Arm Ergometry Exercise Training
Usual Care Control GroupActive comparatorParticipants will receive usual care for PAD from their doctor.
Receives: Behavioral: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal walking distance

    Measured: Measured at baseline and Weeks 6, 12, and 24

  2. Pain-free walking distance

    Measured: Measured at baseline and Weeks 6, 12, and 24

Secondary outcomes (3)
  1. Limb blood flow

    Measured: Measured at baseline and Weeks 6, 12, and 24

  2. Cardiovascular function

    Measured: Measured at baseline and Weeks 6, 12, and 24

  3. Quality of life

    Measured: Measured at baseline and Weeks 6, 12, and 24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2009 (estimated)
  2. Study startJan 2009
  3. Primary completionApr 2014
  4. Study completionApr 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00895635
Sponsor's protocol ID
0803M28683
Other IDs
R01HL090854-01A1
Acronym
EXERT
Status last verified
Oct 2019
First submitted
6 May 2009
Last updated
1 Nov 2019
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Treadmill Exercise Training and Arm Ergometry Exercise Training in people with Intermittent Claudication and Peripheral Vascular Diseases, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal walking distance (time frame: Measured at baseline and Weeks 6, 12, and 24). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in